Literature DB >> 10081651

Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.

H Vestergaard1.   

Abstract

When whole body insulin-stimulated glucose disposal rate is measured in man applying the euglycaemic, hyperinsulinaemic clamp technique it has been shown that approximately 75% of glucose is taken up by skeletal muscle. After the initial transport step, glucose is rapidly phosphorylated to glucose-6-phosphate and routed into the major pathways of either glucose storage as glycogen or the glycolytic/tricarboxylic acid pathway. Glucose uptake in skeletal muscle involves-the activity of specific glucose transporters and hexokinases, whereas, phosphofructokinase and glycogen synthase hold critical roles in glucose oxidation/glycolysis and glucose storage, respectively. Glucose transporters and glycogen synthase activities are directly and acutely stimulated by insulin whereas the activities of hexokinases and phosphofructokinase may primarily be allosterically regulated. The aim of the review is to discuss our present knowledge of the activities and gene expression of hexokinase II (HKII), phosphofructokinase (PFK) and glycogen synthase (GS) in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. My own experimental studies have comprised patients with disorders characterized by insulin resistance like non-insulin-dependent diabetes mellitus (NIDDM) and insulin-dependent diabetes mellitus (IDDM) before and after therapeutic interventions, patients with microvascular angina and patients with severe insulin resistant diabetes mellitus and congenital muscle fiber type disproportion myopathy as well as athletes who are in a state of improved insulin sensitivity. By applying the glucose insulin clamp method in combination with nuclear magnetic resonance 31P spectroscopy to normoglycaemic or hyperglycaemic insulin resistant subjects impairment of insulin-stimulated glucose transport and/or phosphorylation in skeletal muscle has been shown. In states characterized by insulin resistance but normoglycaemia, the activity of HKII measured in needle revealed any genetic variability that contributes to explain the decreased muscle levels of GS mRNA or the decreased activity and activation of muscle GS in NIDDM patients and their glucose tolerant but insulin resistant relatives. Thus, the causes of impaired insulin-stimulated glycogen synthesis of skeletal muscle in normoglycaemic insulin resistant subjects are likely to be found in the insulin signalling network proximal to the GS protein. In insulin resistant diabetic patients the impact of these yet unknown abnormalities may be accentuated by the prevailing hyperglycaemia and hyperlipidaemia. Endurance training in young healthy subjects results in improved insulin-stimulated glucose disposal rates, predominantly due to an increased glycogen synthesis rate in muscle, which is paralleled by an increased total GS activity, increased GS mRNA levels and enhanced insulin-stimulated activation of GS. These changes are probably due to local contraction-dependent mechanisms. Likewise, one-legged exercise training has been reported to increase the basal concentration of muscle GS mRNA in NIDDM patients to a level similar to that seen in control subjects although insulin-stimulated glucose disposal rates remain reduced in NIDDM patients. In the insulin resistant states examined so far, basal and insulin-stimulated glucose oxidation rate at the whole body level and PFK activity in muscle are normal. In parallel, no changes have been found in skeletal muscle levels of PFK mRNA and immunoreactive protein in NIDDM or IDDM patients. In endurance trained subjects insulin-stimulated whole body glucose oxidation rate is often increased. However, depending on the intensity and frequency, physical exercise may induce an increased, a decreased or an unaltered level of muscle PFK activity. In athletes the muscle PFK mRNA is similar to what is found in sedentary subjects whereas the immunoreactive PFK protein concentration is decreased.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081651

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


  11 in total

1.  Antidiabetic effect ofT. arjuna bark extract in alloxan induced diabetic rats.

Authors:  B Ragavan; S Krishnakumari
Journal:  Indian J Clin Biochem       Date:  2006-09

2.  Contrast-enhanced ultrasonography of skeletal muscles for type 2 diabetes mellitus patients with microvascular complications.

Authors:  Ye Song; Yuan Li; Pei-Jun Wang; Yuan Gao
Journal:  Int J Clin Exp Med       Date:  2014-03-15

3.  Molecular characterization of glycogen synthase 1 and its tissue expression profile with type II hexokinase and muscle-type phosphofructokinase in horses.

Authors:  Yusuke Echigoya; Hirotarou Okabe; Takuya Itou; Hideki Endo; Takeo Sakai
Journal:  Mol Biol Rep       Date:  2010-04-11       Impact factor: 2.316

Review 4.  Endothelin-1 in the pathophysiology of obesity and insulin resistance.

Authors:  Haley N Jenkins; Osvaldo Rivera-Gonzalez; Yann Gibert; Joshua S Speed
Journal:  Obes Rev       Date:  2020-07-06       Impact factor: 9.213

5.  Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced β-cell damage in Wistar rat pancreas.

Authors:  G Dhanavathy
Journal:  J Endocrinol Invest       Date:  2015-03-15       Impact factor: 4.256

6.  Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice.

Authors:  Vijay K Yechoor; Mary-Elizabeth Patti; Robert Saccone; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

7.  Glycogen storage disease type III: modified Atkins diet improves myopathy.

Authors:  Sebene Mayorandan; Uta Meyer; Hans Hartmann; Anibh Martin Das
Journal:  Orphanet J Rare Dis       Date:  2014-11-28       Impact factor: 4.123

8.  A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis.

Authors:  Lavinia Palamiuc; Anna Schlagowski; Shyuan T Ngo; Aurelia Vernay; Sylvie Dirrig-Grosch; Alexandre Henriques; Anne-Laurence Boutillier; Joffrey Zoll; Andoni Echaniz-Laguna; Jean-Philippe Loeffler; Frédérique René
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 12.137

9.  Mangiferin Accelerates Glycolysis and Enhances Mitochondrial Bioenergetics.

Authors:  Zhongbo Liu; Pasha Apontes; Ekaterina V Fomenko; Nan Chi; Victor L Schuster; Irwin J Kurland; Jeffrey E Pessin; Yuling Chi
Journal:  Int J Mol Sci       Date:  2018-01-09       Impact factor: 5.923

10.  Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats.

Authors:  Santiagu Stephen Irudayaraj; Sunil Christudas; Stalin Antony; Veeramuthu Duraipandiyan; Al-Dhabi Naif Abdullah; Savarimuthu Ignacimuthu
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.